Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV002008261 | SCV002275175 | uncertain significance | Asphyxiating thoracic dystrophy 5; Senior-Loken syndrome 8 | 2021-02-20 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt WDR19 protein function. This variant has not been reported in the literature in individuals with WDR19-related conditions. This variant is present in population databases (rs756937727, ExAC 0.02%), including at least one homozygous and/or hemizygous individual. This sequence change replaces methionine with isoleucine at codon 246 of the WDR19 protein (p.Met246Ile). The methionine residue is moderately conserved and there is a small physicochemical difference between methionine and isoleucine. |